89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,269,837 | -72.7% | 211,777 | -66.5% | 0.01% | -70.0% |
| Q2 2023 | $11,989,381 | -9.3% | 632,685 | -27.1% | 0.03% | -21.1% |
| Q1 2023 | $13,219,046 | +45.4% | 867,961 | +21.5% | 0.04% | +31.0% |
| Q4 2022 | $9,091,320 | +220.8% | 714,165 | +45.9% | 0.03% | +190.0% |
| Q3 2022 | $2,834,000 | +461.2% | 489,524 | +212.0% | 0.01% | +400.0% |
| Q2 2022 | $505,000 | -39.2% | 156,914 | -28.8% | 0.00% | 0.0% |
| Q1 2022 | $831,000 | +10.2% | 220,418 | +282.3% | 0.00% | 0.0% |
| Q4 2021 | $754,000 | -50.1% | 57,655 | -25.2% | 0.00% | -33.3% |
| Q3 2021 | $1,510,000 | -20.3% | 77,056 | -23.9% | 0.00% | -25.0% |
| Q2 2021 | $1,894,000 | -49.4% | 101,283 | -36.0% | 0.00% | -60.0% |
| Q1 2021 | $3,746,000 | -8.7% | 158,176 | -6.1% | 0.01% | -16.7% |
| Q4 2020 | $4,103,000 | +182.8% | 168,381 | +197.7% | 0.01% | +140.0% |
| Q3 2020 | $1,451,000 | – | 56,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |